OOIR: Observatory of International Research

Papers

(The TQCC of Breast Cancer is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Integrated analysis of cell cycle-related genes in HR+/HER2− breast cancer	123
The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer	55
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	44
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer	41
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can	41
Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial	34
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”	30
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients	27
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study	26
Average lifespan shortened due to breast cancer in Australia, 1990–2015	25
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients	25
Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma	23
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line	23
New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern	22
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	21
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	21
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	21
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence	20
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	20
Factors associated with post acute care utilization after mastectomy for breast cancer patients	19
The role of C1orf50 in breast cancer progression and prognosis	18
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study	17
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan	15
SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer	14
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan	14

Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study	14
The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer	13
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	13
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan	12
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from	12
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer	12
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	12
Relevance of the MHC region for breast cancer susceptibility in Asians	12
Glutaminase (GLS1) gene expression in primary breast cancer	12
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	12
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy	11
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia	11
Prognostic impact of tumor‑associated stroma in triple-negative breast cancer	11
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a	11
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	11
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	11
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study	10
21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer	10
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review	10
Breast cancer screening guidelines: discrepancies raise concerns about validity	10
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches	10
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment	10
6q deletion is frequent but unrelated to patient prognosis in breast cancer	10
Association between chronic pain and quality of life in long-term breast cancer survivors: a prospective analysis	10
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1	10
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes	9
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells	9
Impact of artificial intelligence in breast cancer screening with mammography	9
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiatio	9
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein	9
Color differences of skin paddles using the free flap for autologous breast reconstruction in Asian patients	9
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status	9
FE65 in breast cancer and its clinicopathological significance	9
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population	9
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol	9
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options	9
Association between preoperative grip strength and postoperative upper extremity impairments in patients with breast cancer: a retrospective cohort study	8
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast	8
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees	8
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models	8
Capecitabine with aromatase inhibitors in the front-line therapy for metastatic breast cancer	8
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up	8
Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)	8
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018	7
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?	7
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers	7
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen r	7
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis	7
Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions	7
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes	7

Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort	7
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan	6
Management of nausea and vomiting induced by antibody–drug conjugates	6
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow	6
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	6
Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties	6
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data	6
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy	6
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors	6
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer	6
Performance analysis of screening mammography in Asian women under 40 years	6
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study	6
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer	6
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants	6
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity	6
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome	6
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy	6
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients	6
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes	6
Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women	6
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer	6
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	6
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study	6
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy	6
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT	6
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	6
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results	6
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort	6
Specific types of anxiety regarding radiation therapy in patients with breast cancer: a longitudinal study	5
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	5
FOXA1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population	5
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER databas	5
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced brea	5
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	5
Prospective study of once-daily accelerated partial breast irradiation using 3-dimensional conformal external beam radiotherapy for Japanese women: 12-year outcomes, toxicity, and cosmesis	5
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database	5
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	5
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	5
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis	5
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management	5
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery	5
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +	5
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study	5
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis	5
Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery	5
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients	5
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer	5
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study	5
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual	5
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands	5
Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy	5
Comparative study of the usefulness of adjunctive tomosynthesis in breast cancer screening by mammography and ultrasound in Japan	5
Impact of community-based exercise on fatigue in early breast cancer survivors: identifying potential determinants of change	5
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	5